OpGen > Investor Relations > 2017 Press Releases

2017 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle  
02/14/2017OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting
Data support ability to predict antibiotic susceptibility in hours instead of days GAITHERSBURG, Md., Feb. 14, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced preliminary data demonstrating the ability to rapidly and accurately predict bacterial antibiotic susceptibility using resistance gene profiles. The data were presented at the Advances in Genome Biology and Technology (AGBT) meeting, which is taking place from February 13-16, 2017 in Hollywood Beach, FL. These prelimi... 
 Printer Friendly Version
01/26/2017OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results
Achieves Revenue of Approximately $4.0 Million, a 27% Year Over Year Increase GAITHERSBURG, Md., Jan. 26, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced preliminary unaudited results for the fourth quarter and full year ended December 31, 2016, and summarized 2016 business highlights.  Total revenue for the full year ended December 31, 2016 was approximately $4.0 million, a 27% increase from the $3.2 million recorded for the full year ended December 31, 2015. Total revenue... 
 Printer Friendly Version